Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition by Miguel Quintela-Fandino, Juan V. Apala, Diego Malon, Silvana Mouron, Javier Hornedo, Lucia Gonzalez-Cortijo, Ramon Colomer, Juan Guerra

Get full text

Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgementResea... by Ramon Colomer, Jesús Miranda, Nuria Romero-Laorden, Javier Hornedo, Lucía González-Cortijo, Silvana Mouron, Maria J. Bueno, Rebeca Mondéjar, Miguel Quintela-Fandino

Get full text

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination–deficient stage III/IV ovarian ca... by Jimmy Belotte, Brunella Felicetti, Amanda J. Baines, Ahmed YoussefAgha, Luis Rojas-Espaillat, Ana Godoy Ortiz, Diane Provencher, Raúl Márquez Vázquez, Lucia González Cortijo, Xing Zeng

Get full text

Real world data on the demographic and clinicopathological profile and management of patients with early-stage HER2-positive breast cancer and residual disease treated with adjuvan... by Silvia Antolín Novoa, Santiago Escrivá-de-Romaní, Pablo Tolosa Ortega, Lucía Oliva Fernández, Rafael López López, Ana López González, Pilar de la Morena Barrio, Isabel Echavarria Díaz-Guardamino, José Enrique Alés Martinez, Zita Garate, Lucia González-Cortijo

Get full text

Defining a Standard Set of Patient-Reported Outcomes for Patients With Advanced Ovarian Cancer by Vicente Escudero-Vilaplana, Elsa Bernal, Gema Casado, Roberto Collado-Borrell, Raúl Diez-Fernández, Ana Beatriz Fernández Román, Carlos Folguera, Lucía González-Cortijo, Marta Herrero-Fernández, Gloria Marquina, Gloria Marquina, Concepción Martínez Nieto, Miguel Angel Rodríguez, Ana Rosa Rubio, Patricia Sanmartin-Fenollera, Maria José Vazquez Castillo, Marta Comellas, Eva Maria Guerra

Get full text